Trials / Completed
CompletedNCT01171365
Small Particle Steroids in Refractory Asthma
Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Nottingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether an inhaled steroid with a small particle size can be an additional treatment option in patients with refractory eosinophilic asthma.
Detailed description
We have identified a group of patients with refractory asthma who have ongoing eosinophilic airway inflammation despite high dose inhaled corticosteroids. Traditional inhaled steroids have a relatively proximal airway distribution which may lead to inadequate treatment of the distal airways. We aim to demonstrate that a steroid inhaler with a smaller particle size which targets the distal airways can be a useful additional treatment option in this group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciclesonide | Inhaled ciclesonide 320mcg twice daily |
| DRUG | Placebo | Matched placebo inhaler two inhalations twice daily |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-10-01
- Completion
- 2013-12-01
- First posted
- 2010-07-28
- Last updated
- 2014-01-31
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01171365. Inclusion in this directory is not an endorsement.